Haifa Shen, M.D., Ph.D.

Dr. Shen is a Full Professor in the Department of Nanomedicine at Houston Methodist Research Institute. Dr. Shen is a cancer biologist who specializes in the application of nanotechnology toward the development of cancer therapeutics and immunotherapeutics, as well as delivery systems for various “payloads” (e.g., siRNA, microRNA, chemical compounds) to primary tumors and metastatic lesions. He and his team have developed a nanotechnology-based dendritic cell (Nano-DC) vaccine for HER2-positive breast cancer, and they have demonstrated its effectiveness in murine models of metastatic breast cancer and melanoma.

He serves as Project 1 Co-Leader with Dr. Mittendorf and Dr. Wang.